US89532M1018
US89532M1018
Trevi Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 49.328.000 | 51.524.000 | 4.3% | |
| Operating Income | -49.328.000 | -51.524.000 | 4.3% |
| Pretax Income | -42.823.000 | -47.941.000 | 10.7% |
| Net Income Common Stockholders | -42.759.000 | -47.911.000 | 10.8% |
| -- | -- | -- | |
| -- | -- | -- |